ponatinib

Italy

Drugs containing this active substance

  • ICLUSIG

    It is used in adults to treat certain types of leukemia (chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia) that do not respond to other medicines or that present a specific genetic mutation (T315I).

    Form: tablets, film-coated

    Active substance Dosage
    ponatinib -

    ATC: L01EA05

    Manufacturer: INCYTE BIOSCIENCES DISTRIBUTION B.V.